DrugMay 3, 2023
Tadalafil Tablets, USP 20 mg recall — FDA D-0553-2023
CGMP Deviations
Class IIFDA: OngoingNorthwind Pharmaceuticals LLC
May 2023 recalls — page 18
These records include useful source details for the selected month.
DrugMay 3, 2023
Methapharm Pantoprazole sodium for Injection 40 mg*/vial, Single-dose Vial recall — FDA D-0540-2023
CGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.
Class IIFDA: CompletedMethapharm Inc.
How to use this monthly recall archive
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.